Navigation Links
The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene
Date:7/31/2014

second time this year that the company raised its outlook (Read more: Biogen's Q2 Earnings Surpass Expectations, Tecfidera Shines).

3. AbbVie (NYSE: ABBV-Free Report) also reported strong results with Humira remaining the growth driver. With AbbVie's dependence on Humira having been a source of concern, the upcoming acquisition of UK-based Shire bodes well for the company. This acquisition will not only lead to lower taxes, AbbVie's product portfolio and pipeline will also get a boost (Read more: AbbVie Q2 Earnings Top on Humira Sales, Shire In Focus).

4.Celgene's (Nasdaq: CELG-Free Report) second quarter results were also better-than-expected and the company raised its guidance as well. The key growth driver was cancer drug, Revlimid, which brought in sales of $1.2 billion (Read more: Celgene Beats Q2 Earnings Estimates on Strong Revlimid Sales).

5. Puma Biotechnology's shares skyrocketed a whopping 295% on positive data from late-stage study on its experimental breast cancer treatment, PB272 (neratinib). A 33% improvement in disease free survival was observed compared to placebo. With the positive data, Puma is in a position to file for approval in the first half of 2015 (Read more:

SOURCE Zacks Investment Research, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
2. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
3. Zacks Sell List Highlights: J.C. Penney, Spirit AeroSystems Holdings, The New York Times and Jazz Pharmaceuticals
4. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
5. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
6. Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
7. Zacks Investment Ideas feature highlights: PharMerica, First Defiance Financial, American Railcar Industries and Big 5 Sporting Goods
8. Zacks.com featured expert Kevin Matras highlights: Core Laboratories NV, Invesco Ltd., Medtronic, Inc., Willbros Group Inc. and WuXi PharmaTech Inc.
9. The Zacks Analyst Blog Highlights: Exxon Mobil, Statoil, Chevron, Braskem and Cubist Pharmaceuticals
10. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
11. The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 27, 2015 Bloomage BioTechnology ... announces a strategic cooperation with the South Korean BioTech ... a joint venture Medybloom to develop and promote Type ... China . Medytox, the Botulinum ... and is also the fourth company in the world ...
(Date:7/27/2015)... , July 27, 2015   DocResponse ... technology application in a peer-reviewed study , ... triage: audit study", published in the July issue ... study by Harvard Medical School researchers determined that ... DocResponse listing the correct diagnosis first in standardized ...
(Date:7/27/2015)... , Belgium , July 27, ... VNRX), a life sciences company focused on developing blood-based ... and other conditions, today announced that it has engaged ... organization, Global Specimen Solutions, Inc. (GSS), to support initial ... cancer tests. Under the agreement, GSS ...
Breaking Medicine Technology:Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 2Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 3Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 2Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7
... CVM ) announces that its CEL-1000 immunomodulator was ... against the recombinant hepatitis B,virus protein more quickly than ... was seen within 14 days, most pronounced with a ... up to a 40% increase in antibody,signal at day ...
... Ontario, Sept. 19 ArtJen Complexus Holdings,Corp. (http://www.fbcx.com ... trial with obese type 2 diabetics and an animal ... studied by a major US,west-coast university medical center. The ... fiber that binds dietary fat will involve,overweight but not ...
Cached Medicine Technology:CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein 2CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein 3ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx 2
(Date:7/27/2015)... ... ... With a new charity program in the Chico, CA area, Gary Short & ... of deaths and injuries occurring from police pursuits, and announced that they will be ... police to find better and safer ways to conduct pursuits. To support this wonderful ...
(Date:7/27/2015)... ... July 27, 2015 , ... At Champagne Smiles, they ... that tooth loss can incur a lot of stress, pain, discomfort and embarrassment, which ... The All-On-4™ treatment reaps the benefits of implants with the cost savings of ...
(Date:7/27/2015)... ... , ... In a creative effort to provide clear information about the process ... at Dove Tree in Lubbock has shared a new infographic to illustrate the process. ... Both the nationally recognized collegiate program and traditional adult program at The Ranch at ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... SupplyLogic, a ... executive blog on its newly redesigned company Website. In the blog, Founder and CEO ... of a popular comedian: "Comedian George Wallace always asks: ‘Why is it the closer ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... serving communities in and around Dallas, Texas, is announcing a joint charity effort ... support and employment resources for American veterans who are returning from overseas. , ...
Breaking Medicine News(10 mins):Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 2Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 4Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 2Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 3Health News:SupplyLogic Releases First Executive Blog on Supply Chain Management Issues 2Health News:The Tedesco Agency of North Dallas and Non-Profit IAVA Announce Joint Charity Effort to Support American Veterans 2
... Nearly one in 10 obstetricians in a new study ... emotional toll of stillbirths and infant deaths. , ... survey by researchers at the University of Michigan Health ... toll on them personally. , "Our survey reveals that ...
... to Launch a Program in Support of the Heightened National Response ... ... Platinum selling,singer/songwriter/producer Lyfe Jennings kicked off his Baby I,m a Star,summer concert ... with the tour, Lyfe is partnering with Music World,Entertainment to launch a ...
... to develop rheumatoid arthritis in adulthood as their average ... the Annals of the Rheumatic Diseases . , ... which argues that certain conditions and diseases in adult ... Diabetes, coronary heart disease, and high blood pressure, for ...
... (p. 26). In this second annual,double issue, Newsweek poses ... whether politicians should pander, whether having,children makes you happier ... global warming. Readers can also test their Global IQ ... issue. Try these:, 1. How many presidents achieved ...
... to regulate emotions can determine both neurological and physiological ... University and Rutgers University neuroscientists has discovered. The findings, ... Nature Neuroscience , shed light on how the ... Previous research has demonstrated these strategies can alter responses ...
... a replacement organ that never arrives , , SUNDAY, June ... clinging to life this very second, and their only ... The science of organ transplantation has improved by leaps ... died in 2005, waiting for a replacement organ that ...
Cached Medicine News:Health News:Stillbirths, infant deaths lead to anxiety, guilt and stress among obstetricians 2Health News:Lyfe Jennings Launches Summer Tour and HIV/AIDS Awareness Initiative 2Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 2Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 3Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 4Health News:NEWSWEEK: Media Lead Sheet - July 7-14, 2008 Double Issue (On Newsstands Monday, June 30) 5Health News:NYU, Rutgers study shows how using mental strategies can alter the brain's reward circuitry 2Health News:Organ Donation: An Advancing Science Hindered by Supply Shortages 2Health News:Organ Donation: An Advancing Science Hindered by Supply Shortages 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: